Pasithea Therapeutics Statistics
Share Statistics
Pasithea Therapeutics has 70.33M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 70.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 62.02% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,754 |
| FTD / Avg. Volume | 32.27% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.4 |
| P/FCF Ratio | n/a |
| PEG Ratio | undefined |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Pasithea Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.34,
with a Debt / Equity ratio of undefined.
| Current Ratio | 6.34 |
| Quick Ratio | 6.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | undefined |
Financial Efficiency
Return on Equity is -0.68% and Return on Invested Capital is -68.05%.
| Return on Equity | -0.68% |
| Return on Assets | -0.61% |
| Return on Invested Capital | -68.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,995,207.25 |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | -16.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 69.49% in the
last 52 weeks. The beta is 0.82, so Pasithea Therapeutics's
price volatility has been higher than the market average.
| Beta | 0.82 |
| 52-Week Price Change | 69.49% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 48.83 |
| Average Volume (20 Days) | 14,730 |
Income Statement
| Revenue | n/a |
| Gross Profit | -648.45K |
| Operating Income | -15.98M |
| Net Income | -15.96M |
| EBITDA | -15.33M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -12.65 |
Full Income StatementBalance Sheet
The company has 16.33M in cash and 81.68K in
debt, giving a net cash position of 16.25M.
| Cash & Cash Equivalents | 16.33M |
| Total Debt | 81.68K |
| Net Cash | 16.25M |
| Retained Earnings | -35.32M |
| Total Assets | 18.64M |
| Working Capital | 9.12B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -13.43M
and capital expenditures -34.3K, giving a free cash flow of -12.85M.
| Operating Cash Flow | -13.43M |
| Capital Expenditures | -34.3K |
| Free Cash Flow | -12.85M |
| FCF Per Share | -10.18 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
